Business Context and Reporting Period
This Form 8-K filing by Nerdy Inc. (NYSE: NRDY) is dated November 12, 2024. The report addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the Company's compliance with continued listing standards.
Key Financial Metrics
- Cash and Liquidity: As of the end of the third quarter, the Company reported $65.0 million in cash on its balance sheet.
- Debt: The Company reported no debt.
- Stock Price: The average closing price of Class A Common Stock was less than $1.00 over a consecutive 30 trading-day period, triggering the non-compliance notice.
- Revenue and Profit: The filing text does not provide specific revenue, profit, or margin figures for the current period.
Material Changes and Events
On November 12, 2024, Nerdy Inc. received a notice from the NYSE stating it is not in compliance with Section 802.01C of the NYSE Listed Company Manual due to the low stock price. The Company intends to notify the NYSE of its plan to cure this deficiency. The stock will continue to trade on the NYSE during the cure period, provided other listing standards are met.
Guidance, Outlook, and Risks
- Cure Plan: The Company has a six-month period to regain compliance by achieving a closing share price of at least $1.00 and an average closing price of at least $1.00 over a 30-day period ending on the last trading day of any calendar month.
- Reverse Stock Split: The Company may consider a reverse stock split, subject to stockholder approval at the next annual meeting, if necessary to cure the deficiency.
- Operational Impact: Management states the notice is not anticipated to impact ongoing business operations or SEC reporting requirements.
- Risks: Forward-looking statements highlight risks including limited operating history, history of net losses, customer acquisition challenges, intellectual property claims, independent contractor classification issues, and regulatory risks related to minors and artificial intelligence.
Investor Verification Checklist
- Verify the current trading price of NRDY to assess the likelihood of meeting the $1.00 threshold within the six-month cure period.
- Monitor announcements regarding the potential reverse stock split and the timing of the required stockholder vote.
- Review the Company's most recent Form 10-Q or 10-K for detailed revenue, net loss, and cash burn rates not included in this 8-K.
- Confirm the status of the $65.0 million cash balance to ensure sufficient liquidity remains for operations during the cure period.